| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1092852900019489 |
| P698 | PubMed publication ID | 15685125 |
| P50 | author | Joseph Biederman | Q6281524 |
| Megan Aleardi | Q114572757 | ||
| Janet Wozniak | Q114735122 | ||
| P2093 | author name string | Eric Mick | |
| Thomas Spencer | |||
| Mary Ann McDonnell | |||
| Richard Falzone | |||
| P2860 | cites work | Pediatric mania: a developmental subtype of bipolar disorder? | Q34052800 |
| Mania-Like Symptoms Suggestive of Childhood-Onset Bipolar Disorder in Clinically Referred Children | Q34303286 | ||
| A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder | Q40680619 | ||
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 | ||
| Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial | Q44476520 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. | Q50302507 | ||
| Bipolar disorder during adolescence and young adulthood in a community sample. | Q51968691 | ||
| The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. | Q51988680 | ||
| Suicide among female adolescents: characteristics and comparison with males in the age group 13 to 22 years. | Q52013366 | ||
| Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. | Q53969282 | ||
| Risperidone in adolescents with schizophrenia: an open pilot study | Q73308908 | ||
| P433 | issue | 2 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 141-148 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | C N S Spectrums | Q15750260 |
| P1476 | title | Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review | |
| P478 | volume | 10 |
| Q46505295 | A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic |
| Q37061277 | Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth |
| Q35330010 | An open-label study of aripiprazole in children with a bipolar disorder |
| Q40176997 | An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. |
| Q28073540 | Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis |
| Q46952830 | Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial |
| Q33858314 | Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study |
| Q45990613 | Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. |
| Q84634363 | Childhood disintegrative disorder |
| Q37155306 | Comparison of aripiprazole and other atypical antipsychotics for pediatric bipolar disorder: a retrospective chart review of efficacy and tolerability |
| Q46017126 | Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats. |
| Q43107638 | Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats. |
| Q37299210 | Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review |
| Q35242995 | High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study |
| Q36284465 | Management options for bipolar disorder in children and adolescents |
| Q34613057 | Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders |
| Q22242775 | Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder |
| Q33819889 | Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic |
| Q34600500 | Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents |
| Q36648780 | Psychopharmacology of pediatric bipolar disorder: a review |
| Q33727450 | Research strategies that result in optimal data collection from the patient medical record |
| Q46494592 | The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen. |
| Q80092076 | Treating persistent adolescent aggression |
Search more.